This resolution expresses strong support for designating July 16, 2025, as Glioblastoma Awareness Day . Its primary goal is to significantly increase public understanding of glioblastoma, which is identified as the most common, aggressive, and deadly malignant brain tumor with a very low survival rate and high out-of-pocket costs for patients. The resolution honors individuals who have succumbed to or are currently battling glioblastoma, along with their families and caregivers. It advocates for enhanced efforts to develop more effective treatments, recognizing the critical role of molecular biomarker testing in diagnosis and care. Furthermore, it urges a collaborative approach to brain tumor research among governmental, private, and nonprofit organizations, emphasizing the need for continued investments in research, including through initiatives like the Glioblastoma Therapeutics Network, to advance understanding and treatment.